Craddock V M, Henderson A R, Gash S
J Cancer Res Clin Oncol. 1984;108(1):30-5. doi: 10.1007/BF00390970.
The susceptibility of rat brain to induction of cancer by N-nitroso-N-ethyl-urea (NEU) increases dramatically from a very low level in the 12 day foetus to a maximum at the time of birth, and then decreases with age. Liver tumors are rarely induced by a single treatment with NEU at any age. If induction of cancer by nitroso-alkyl-ureas depends on replication of DNA containing the mispairing base O6-alkylguanine, susceptibility would reflect the balance between the protective effect of removal of the base by repair mechanisms and the potentiating effect of cell replication. The capacity of tissues to remove O6-alkyl-guanine from DNA depends on the amount of alkyl acceptor protein (AAP) present. To study the concept that carcinogenesis results from replication of alkylated DNA, the AAP contents and relative rates of DNA replication were studied in brain and liver of rats at various stages of development, from the 12 day foetus to the 48 week old rat. Replication in liver was approximately ten times higher than in intra-cranial contents at each stage of development studies. The AAP content was higher in the 12 day foetal brain than later, decreasing to low levels as susceptibility to NEU increased until the time of birth, and then remaining low in the adult. The peak sensitivity of brain therefore corresponds to the time at which AAP content is low and rate of DNA replication is high. With liver, AAP levels are low in the foetus, although higher than in brain, and increase after birth. The higher level of AAP in the foetal liver compared with that of brain is possibly sufficient to explain why cancer is not induced in liver in spite of the high rate of DNA replication. The results are consistent with the concept that replication of alkylated DNA is an essential event in initiation. There may be no quantitative relationship between replication and repair and susceptibility to cancer on comparison of different tissues, owing to the fact that, at the cellular level, cancer is a rare event. The amount of mispairing at replication necessary to bring it about may depend on the detailed organisation of the genome, and hence on cell type.
大鼠脑对N-亚硝基-N-乙基脲(NEU)诱发癌症的易感性从12日龄胎儿时的极低水平急剧增加,在出生时达到最高,然后随年龄增长而降低。在任何年龄,单次使用NEU很少诱发肝肿瘤。如果亚硝基烷基脲诱发癌症取决于含有错配碱基O6-烷基鸟嘌呤的DNA复制,那么易感性将反映修复机制去除该碱基的保护作用与细胞复制的增强作用之间的平衡。组织从DNA中去除O6-烷基鸟嘌呤的能力取决于烷基受体蛋白(AAP)的含量。为了研究致癌作用源于烷基化DNA复制的概念,研究了从12日龄胎儿到48周龄大鼠不同发育阶段大鼠脑和肝中的AAP含量以及DNA复制的相对速率。在发育研究的每个阶段,肝脏中的复制比颅内组织中的复制高约十倍。12日龄胎儿脑内的AAP含量高于之后的时期,随着对NEU易感性增加直至出生时降至低水平,然后在成年期保持低水平。因此,脑的峰值敏感性对应于AAP含量低且DNA复制速率高的时间。对于肝脏,胎儿期AAP水平较低,尽管高于脑内,且出生后会升高。胎儿肝脏中AAP水平高于脑内,这可能足以解释尽管DNA复制速率很高但肝脏中为何未诱发癌症。这些结果与烷基化DNA复制是启动过程中的关键事件这一概念一致。由于在细胞水平上癌症是罕见事件,不同组织在复制与修复以及癌症易感性之间可能不存在定量关系。导致癌症发生所需的复制时错配量可能取决于基因组的详细组织,因此取决于细胞类型。